Does Aetna Cover Weight Loss Treatment in Idaho? A 2026 Guide

Last updated: July 14, 2026

If you have Aetna insurance in Idaho and are looking into prescription weight loss treatment, one of the most important recent developments is this: Zepbound (tirzepatide) was reinstated to CVS/Caremark commercial formularies effective October 1, 2026, following its removal in 2025. This means Idaho Aetna members who were previously blocked from Zepbound coverage under their pharmacy benefit may now have a pathway to access it — subject to prior authorization (PA) and clinical criteria.

This guide explains what Aetna may cover for weight loss in Idaho in 2026, how CVS/Caremark’s formulary applies to prescription weight loss medications, the prior authorization process, and how to connect with a provider who can help you navigate your options.

Considering weight loss treatment? Klarity Health’s licensed providers can evaluate your eligibility and help you understand what your Aetna plan may cover. See if you may qualify →

Does Aetna Cover Weight Loss Treatment in Idaho?

Aetna operates in Idaho through two entities: Aetna Health of Utah Inc. (HMO plans requiring PCP coordination) and Aetna Life Insurance Company (PPO and EPO plans with more direct specialist access). Whether your plan covers weight loss treatment depends on several factors specific to your policy.

Unlike mental health and substance use disorder services — which are governed by Idaho’s mental health parity law (Idaho Code § 41-3901 et seq.) and the federal Mental Health Parity and Addiction Equity Act (MHPAEA) — weight loss treatment coverage is not subject to a comparable mandatory parity framework. Coverage is instead governed by:

• The Affordable Care Act (ACA) Essential Health Benefits (EHB) — for fully insured individual and small group plans
• ERISA (Employee Retirement Income Security Act) — for self-funded employer group plans, which are not required to follow state benefit mandates
• Your specific plan’s Summary of Benefits and Coverage (SBC) — which defines exactly what is and is not covered for your enrollment

Idaho Code § 41-3901 et seq. is a mental health and substance use disorder parity statute only. It does not require Aetna to cover weight loss treatment, obesity medications, or bariatric services. Weight loss coverage on your Aetna plan is a plan design choice, not a state mandate.

Idaho is home to significant agricultural, food processing, and mining industries. Many workers in these sectors are enrolled in large employer self-funded ERISA plans. If you are covered through a self-funded employer plan, your weight loss benefits are determined entirely by your employer’s plan design — and Idaho state insurance laws, including any future weight loss benefit requirements, would not apply to your plan.

To confirm whether your specific Aetna plan covers prescription weight loss medications, contact Aetna Member Services at 1-800-872-3862 and request a benefits verification for obesity pharmacotherapy (ICD-10: E66.x).

Key Update: Zepbound Reinstated on CVS/Caremark October 1, 2026

CVS/Caremark — the pharmacy benefit manager (PBM) for Aetna commercial plans — removed tirzepatide (Zepbound) from its commercial formularies in 2025. Following a formulary review and the announcement of a new preferred pricing arrangement, CVS/Caremark reinstated Zepbound to its commercial formulary effective October 1, 2026.

What this means for Idaho Aetna members:

• Zepbound is now formulary-eligible under CVS/Caremark commercial plans (Tier 3–4, PA required)
• Members who were previously denied Zepbound coverage due to the formulary removal may have a new pathway to access
• Prior authorization remains required — clinical criteria (BMI ≥30, or BMI ≥27 with a qualifying weight-related comorbidity) apply
• Members on Wegovy who prefer to explore Zepbound should speak with their prescribing provider about a transition request

This is distinct from the Medicare Advantage GLP-1 Bridge program, which is a CMS program for eligible Medicare Advantage members only and does not apply to Aetna commercial or employer group plans in Idaho. If you have Aetna commercial coverage, the Medicare GLP-1 Bridge is not relevant to your benefits.

CVS/Caremark Weight Loss Medication Formulary (2026)

Aetna commercial plans in Idaho use CVS/Caremark as their pharmacy benefit manager. The following table reflects the typical CVS/Caremark formulary structure for FDA-approved weight loss medications. Exact tier placement and PA requirements vary by specific plan; verify your coverage using your plan’s drug lookup tool or by calling CVS/Caremark at 1-800-552-8159.

Ozempic (semaglutide 0.5–2mg) and Mounjaro (tirzepatide 2.5–15mg) are FDA-approved for type 2 diabetes, not obesity. If your prescriber submits a PA for weight loss using these medications, CVS/Caremark will typically require the obesity-indicated versions (Wegovy or Zepbound) to be tried first, or will process the PA under the indication submitted. Always verify the specific indication on your PA request with your provider.

Electronic Prescribing of Controlled Substances (EPCS): Not Applicable to Weight Loss Medications

Idaho Code § 37-2726A requires electronic prescribing for Schedule II controlled substances. However, no FDA-approved weight loss medication is classified as Schedule II:

• GLP-1 receptor agonists (Wegovy, Zepbound, Saxenda): Non-scheduled
• Contrave (naltrexone-bupropion): Non-scheduled
• Orlistat: Non-scheduled
• Phentermine and Qsymia: Schedule IV (not Schedule II) — EPCS requirements under Idaho Code § 37-2726A do not apply to Schedule IV substances

EPCS is therefore entirely inapplicable to the weight loss medication category. Klarity Health providers can prescribe all non-scheduled and Schedule IV weight loss medications consistent with Idaho prescribing law and telehealth regulations.

Prior Authorization: What Aetna and CVS/Caremark Typically Require

Most prescription weight loss medications on the CVS/Caremark formulary require prior authorization. The typical clinical criteria Aetna/CVS Caremark may apply include:

• BMI ≥30 kg/m², or
• BMI ≥27 kg/m² with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea)
• Documentation of previous weight loss attempts (dietary counseling, exercise program)
• Absence of contraindications (e.g., personal or family history of medullary thyroid cancer for GLP-1 RAs; pregnancy)
• Step therapy may be required on some plans — orlistat or Contrave before Wegovy/Zepbound

PA timelines under Aetna/CVS Caremark:

• Standard PA: decision within 72 hours of receiving complete documentation
• Urgent PA: decision within 24 hours
• Appeal of denial: 30–60 days standard; expedited appeal within 72 hours for urgent clinical need
• External independent review: available if internal appeal is denied; required under Idaho insurance law for fully insured plans
• Idaho DOI complaints: 1-800-721-3272

What Weight Loss Services May Aetna Cover Beyond Medications?

Depending on your specific Aetna plan, the following weight management services may be covered in addition to prescription medications:

• Obesity evaluation and diagnosis — BMI screening, metabolic panel, comprehensive medical history
• Intensive behavioral therapy (IBT) for obesity — CMS-backed preventive service covered at 100% for Medicare beneficiaries; may be covered under ACA preventive services for qualifying commercial plans
• Registered dietitian consultations — may require medical necessity documentation
• Bariatric surgery evaluation — criteria typically include BMI ≥40, or ≥35 with comorbidities, and documentation of supervised weight loss attempts; pre-authorization required
• Telehealth weight management visits — Aetna generally covers telehealth services on par with in-person visits for eligible plan types

Coverage for these services varies significantly by plan type (HMO vs. PPO/EPO), whether your plan is fully insured or self-funded, and your specific benefit year. Review your Summary of Benefits and Coverage or call Aetna at 1-800-872-3862 to confirm coverage details.

Aetna HMO vs. PPO/EPO: What’s the Difference for Weight Loss?

In Idaho, Aetna offers both HMO and PPO/EPO plan types:

• Aetna HMO (Aetna Health of Utah Inc.): Typically requires a PCP referral before seeing a specialist, including a bariatric surgeon or obesity medicine physician. Your PCP coordinates your care. Weight loss medication PA is still submitted through CVS/Caremark regardless of plan type.
• Aetna PPO/EPO (Aetna Life Insurance Company): Generally allows direct access to in-network specialists without a referral. Provides more flexibility to seek out obesity medicine specialists or bariatric programs within the Aetna network.

If you are on an HMO plan and want to pursue prescription weight loss treatment, start with your PCP. If you are on a PPO/EPO, you may be able to work directly with a telehealth provider like Klarity Health to initiate an evaluation and PA submission.

Weight Loss Treatment Through Klarity Health

Klarity Health connects patients with licensed medical providers who specialize in telehealth weight management. Our network of 2,000+ providers can evaluate your eligibility for prescription weight loss medications, submit prior authorization requests on your behalf, and coordinate ongoing monitoring — all from the convenience of a telehealth visit.

Ready to explore your options? See if you may qualify for prescription weight loss treatment through Klarity Health. Check your eligibility →

Contacts and Resources

• Aetna Member Services (Idaho): 1-800-872-3862 | aetna.com
• CVS/Caremark Pharmacy Benefits: 1-800-552-8159 | caremark.com
• Idaho Department of Insurance (DOI): 1-800-721-3272 | doi.idaho.gov
• SAMHSA National Helpline: 1-800-662-4357 (for co-occurring mental health support)
• Obesity Medicine Association: obesitymedicine.org (find board-certified obesity medicine specialists)

Frequently Asked Questions

Is Zepbound currently covered under my Aetna plan in Idaho?

CVS/Caremark reinstated Zepbound (tirzepatide) to commercial formularies effective October 1, 2026, following its removal in 2025. Zepbound is typically placed at Tier 3–4 with prior authorization required. Your specific plan may have different tier placement or additional criteria. Verify coverage by calling CVS/Caremark at 1-800-552-8159 or using the drug lookup tool on your Aetna member portal.

Does Aetna cover Ozempic for weight loss in Idaho?

Ozempic (semaglutide 0.5–2mg) is FDA-approved for type 2 diabetes management, not obesity. For weight loss, the FDA-approved semaglutide product is Wegovy (semaglutide 2.4mg). CVS/Caremark typically processes PAs based on the FDA-approved indication. If you are seeking weight loss coverage, your provider should prescribe Wegovy rather than Ozempic. Similarly, Mounjaro is the diabetes indication; Zepbound is the FDA-approved obesity indication for tirzepatide.

Does Idaho law require Aetna to cover weight loss medications?

No. Idaho Code § 41-3901 et seq. is a mental health and substance use disorder parity law only — it does not require coverage for weight loss treatments or obesity medications. Coverage depends on your specific plan’s benefits, whether your plan is fully insured or self-funded, and ACA/ERISA frameworks. Many self-funded employer plans in Idaho — common in the agricultural, food processing, and mining sectors — are not subject to state insurance mandates at all.

Can a Klarity Health provider prescribe weight loss medications in Idaho?

Klarity Health’s licensed providers may prescribe FDA-approved weight loss medications consistent with Idaho telehealth prescribing regulations. GLP-1 receptor agonists (Wegovy, Zepbound) and other non-scheduled weight loss medications are eligible for telehealth prescribing. If your plan requires PA, your Klarity provider can submit the PA request with appropriate clinical documentation. Schedule IV medications (phentermine, Qsymia) may have additional quantity limit considerations.

What if my Aetna PA is denied for a weight loss medication?

You have the right to appeal a PA denial. First, request an internal appeal through Aetna within the timeframe specified in your denial notice (typically 60–180 days depending on plan type). If the internal appeal is denied, you can request an external independent review through an independent organization. For fully insured plans in Idaho, external review rights are available under Idaho insurance law. Contact the Idaho Department of Insurance at 1-800-721-3272 if you believe your plan is not following required appeal processes.

Disclaimer: This guide is for informational purposes only and does not constitute insurance, legal, or medical advice. Coverage details vary by plan. Always verify your specific benefits with Aetna before beginning treatment. Coverage described reflects typical CVS/Caremark formulary structure as of 2026 and is subject to change.